Real World Insights

Providing Pharma & Biopharma with RWD & AI-Driven Insights on Patient Populations Affected by Speciality & Rare Diseases

Posts about

Technology

2023 Survey: Automation Is Ubiquitous for Orphan and Specialty Drug Commercialization

87% of Biopharma Respondents Use AI/ML for Post-Market Activities, But Key Missed Opportunities...

Using ML/AI to Find the Right Patients at the Right Time: A Conversation with AVEO Oncology

By: Dan Fisher, Principal, IPM.ai

Ganesh Rajaratnam, Senior Director of Commercial Operations,...

IPM.ai's Clinical Trial Recruitment Solution Featured in MM&M

By: Dan Fisher, Principal, IPM.ai

Allison Rhee of MM&M reports on IPM.ai's answer to patient...

Using ML and AI to Infer HCP Specialties

By: Dan Fisher, Principal, IPM.ai

Specialty Physician Identification: Your Best Targets Could Be...

Machine Learning Times IPM.ai Interview

By: Dan Fisher, Principal, IPM.ai

In anticipation of their upcoming conference presentation at ...

Using AI and Real World Data to Do What’s Right for Patients

Driving Optimal Outcomes through the Use of Artificial Intelligence and Real World Data